Drug Eluting Stent Market, By Polymer-based Coatings (Non-biodegradable Polymer-based, Biodegradable Polymer-based), Polymer-free Coatings (Micro Porous Surface, Microstructured Surface, Slotted Tubular Surface, Nanoporous Surface), By Application (Coronary Artery Disease, Peripheral Artery Disease), And Segment Forecasts To 2024

Published: Aug, 2016 | Pages: 75 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The global drug eluting stent market is anticipated to reach USD 9.2 billion by 2024, according to a new report by Grand View Research, Inc. The increasing geriatric population and the high prevalence of artery diseases are the major factors driving the market growth. Sedentary lifestyles, unhealthy dietary habits, and lack of exercise are some of the factors resulting in the increased prevalence of atherosclerosis. As a result, the demand for Drug Eluting Stents (DES) is escalating as atherosclerosis is widely treated using DES. In addition, a constant decline in the price coupled with the reimbursement coverage is spurring the adoption of DES in the treatment of arterial diseases.

Risks, such as thrombosis and disruption of regrowth of endothelial tissues associated with DES, are challenging the market growth. In addition, stringent regulatory approval guidelines are impeding the market growth by restricting the entry of advanced DES, such as bioabsorbable products, in the developed countries.

Presently, the DES market is highly fragmented with the presence of many players competing with each other. The key players in the market are implementing mergers and acquisitions strategies to strengthen their position in the market by the expansion of market share and customer base.

Further key findings from the study suggest:

The polymer-based coating stent segment was dominating the global market and is estimated to remain dominant throughout the forecast period. The increasing adoption of biodegradable stents is mainly driving the growth of the polymer-based coating stents segment.

The biodegradable polymer-based drug eluting stents are anticipated to have a high demand during the forecast period due to aminimally invasive technique and lesser risk of late stent thrombosis.

The demand for polymer-free drug eluting stents is going to increase considerably with new products entering the market, especially in emerging countries such as Brazil, Mexico, and South Africa.

China, India, Brazil, and South Africa are anticipated to register a significant growth in the near future owing to the rising patient awareness related to DES, presence of the largest pool of geriatric population prone to arterial diseases, and the surging prevalence of chronic diseases such as diabetes and cardiac disorders

Less stringent regulatory approval procedures in Asia Pacific are offering the easy entry of the new products into the market.

Some key players operating in the market include Boston Scientific Corporation, Medtronic, Inc., Abbott Laboratories, Biosensors International Group, Lepu Medical Technology, Biotronik, Stentys, and Terumo Medical Corporation.

North America dominated the global market with a share of 40% in 2015. Technological advancements, such as the introduction of biodegradable stents primarily, led to the highest revenue generation in the region.

In addition, the reimbursement coverage, the presence of a large target patient population, and a well-defined regulatory framework are a few factors that are positively affecting the market.

 Table of Contents


Chapter 1 Executive Summary 
Chapter 2 Market Snapshot 
Chapter 3 Market Variables, Trends & Scope 
                       3.1 Market segmentation & scopes 
                           3.1.1 Market Driver Analysis 
                           3.1.2 Market Restraint Analysis
                       3.2 Penetration & growth prospect mapping 
                       3.3 Drug Eluting Stents - SWOT Analysis, By Factor (political & legal, economic, and technological) 
                       3.4 Industry Analysis - Porter's 
Chapter 4 Market Categorization 1: Drug Coating 
                       4.1 Polymer-based Coatings
                           4.1.1 Non - biodegradable Polymers 
                           4.1.2 Biodegradable Polymers
                       4.2 Polymer free Coatings
                           4.2.1 Micro porous Surface
                           4.2.2 Micro structured Surface
                           4.2.3 Slotted Tubular Surface
                           4.2.4 Nanoporous Surface
Chapter 5 Market Categorization 2: Application Outlook 
                       5.1 Coronary Artery Disease
                       5.2 Peripheral Artery Disease
Chapter 6 Market Categorization 3: Regional Estimates & Trend Analysis, by Product 
                       6.1 Drug Eluting Stent Market share by region, 2014 & 2024 
                       6.2 North America market share by product, 2014 & 2024
                           6.2.1 U.S. market share by product, 2014 & 2024
                           6.2.2 Canada market share by product, 2014 & 2024
                       6.3 North America market share by application, 2014 & 2024
                           6.3.1 U.S. market share by application, 2014 & 2024
                           6.3.2 Canada market share by application, 2014 & 2024
                       6.4 Europe market share by product, 2014 & 2024
                           6.4.1 Germany market share by product, 2014 & 2024
                           6.4.2 U.K. market share by product, 2014 & 2024
                       6.5 Europe market share by application, 2014 & 2024
                           6.5.1 Germany market share by application, 2014 & 2024
                           6.5.2 U.K. market share by application, 2014 & 2024
                       6.6 Asia Pacific market share by product, 2014 & 2024
                           6.6.1 China market share by product, 2014 & 2024
                           6.6.2 Japan market share by product, 2014 & 2024
                       6.7 Asia Pacific market share by application, 2014 & 2024
                           6.7.1 China market share by application, 2014 & 2024
                           6.7.2 Japan market share by application, 2014 & 2024
                       6.8 Latin America market share by product, 2014 & 2024
                           6.8.1 Brazil market share by product, 2014 & 2024
                           6.8.2 Mexico market share by product, 2014 & 2024
                       6.9 Latin America market share by application, 2014 & 2024
                           6.9.1 Brazil market share by application, 2014 & 2024
                           6.9.2 Mexico market share by application, 2014 & 2024
                       6.10 MEA market share by product, 2014 & 2024
                           6.10.1 South Africa market share by product, 2014 & 2024
                       6.11 MEA market share by application, 2014 & 2024
                           6.11.1 South Africa market share by application, 2014 & 2024
Chapter 7 Competitive Landscape 
                       7.1 Strategy framework 
                       7.2 Market participation categorization 
                       7.3 Company Profiles 
                           7.3.1 Abbott Laboratories 
                                  7.3.1.1 Company Overview 
                                  7.3.1.2 Financial Performance 
                                  7.3.1.3 Product Benchmarking 
                                  7.3.1.4 Strategic Initiatives 
                           7.3.2 Boston Scientific Corporation 
                                  7.3.2.1 Company Overview 
                                  7.3.2.2 Financial Performance 
                                  7.3.2.3 Product Benchmarking 
                                  7.3.2.4 Strategic Initiatives 
                           7.3.3 Terumo Corporation 
                                  7.3.3.1 Company Overview 
                                  7.3.3.2 Financial Performance 
                                  7.3.3.3 Product Benchmarking 
                                  7.3.3.4 Strategic Initiatives 
                           7.3.4 Medtronic 
                                  7.3.4.1 Company Overview 
                                  7.3.4.2 Financial Performance 
                                  7.3.4.3 Product Benchmarking 
                                  7.3.4.4 Strategic Initiatives 
                           7.3.5 Biosensors International 
                                  7.3.5.1 Company Overview 
                                  7.3.5.2 Financial Performance 
                                  7.3.5.3 Product Benchmarking 
                                  7.3.5.4 Strategic Initiatives 
                           7.3.6 Cook Medical 
                                  7.3.6.1 Company Overview 
                                  7.3.6.2 Financial Performance 
                                  7.3.6.3 Product Benchmarking 
                                  7.3.6.4 Strategic Initiatives 
                           7.3.7 Envision Scientific 
                                  7.3.7.1 Company Overview 
                                  7.3.7.2 Financial Performance 
                                  7.3.7.3 Product Benchmarking 
                                  7.3.7.4 Strategic Initiatives 
                           7.3.8 Biotronik 
                                  7.3.8.1 Company Overview 
                                  7.3.8.2 Financial Performance 
                                  7.3.8.3 Product Benchmarking 
                                  7.3.8.4 Strategic Initiatives 
                           7.3.9 Lepu Medical 
                                  7.3.9.1 Company Overview 
                                  7.3.9.2 Financial Performance 
                                  7.3.9.3 Product Benchmarking 
                                  7.3.9.4 Strategic Initiatives 
                           7.3.10 Stentsys 
                                  7.3.10.1 Company Overview 
                                  7.3.10.2 Financial Performance 
                                  7.3.10.3 Product Benchmarking 
                                  7.3.10.4 Strategic Initiatives

List of Tables


TABLE 1 North America Drug Eluting Stent Market, by product, 2013 - 2024 (USD Million)
TABLE 2 U.S. Drug Eluting Stent Market, by product, 2013 - 2024 (USD Million) 
TABLE 3 Canada Drug Eluting Stent Market, by product, 2013 - 2024 (USD Million) 
TABLE 4 Europe Drug Eluting Stent Market, by product, 2013 - 2024 (USD Million) 
TABLE 5 Germany Drug Eluting Stent Market, by product, 2013 - 2024 (USD Million) 
TABLE 6 U.K. Drug Eluting Stent Market, by product, 2013 - 2024 (USD Million) 
TABLE 7 Spain Drug Eluting Stent Market, by product, 2013 - 2024 (USD Million) 
TABLE 8 Rest of Europe Drug Eluting Stent Market, by product, 2013 - 2024 (USD Million) 
TABLE 9 Asia Pacific Drug Eluting Stent Market, by product, 2013 - 2024 (USD Million) 
TABLE 10 China Drug Eluting Stent Market, by product, 2013 - 2024 (USD Million) 
TABLE 11 Japan Drug Eluting Stent Market, by product, 2013 - 2024 (USD Million) 
TABLE 12 India Drug Eluting Stent Market, by product, 2013 - 2024 (USD Million) 
TABLE 13 Rest of Asia Pacific Drug Eluting Stent Market, by product, 2013 - 2024 (USD Million) 
TABLE 14 Latin America Drug Eluting Stent Market, by product, 2013 - 2024 (USD Million) 
TABLE 15 Brazil Drug Eluting Stent Market, by product, 2013 - 2024 (USD Million) 
TABLE 16 Mexico Drug Eluting Stent Market, by product, 2013 - 2024 (USD Million) 
TABLE 17 Rest of Latin America Drug Eluting Stent Market, by product, 2013 - 2024 (USD Million)
TABLE 18 MEA Drug Eluting Stent Market, by product, 2013 - 2024 (USD Million) 
TABLE 19 South Africa Drug Eluting Stent Market, by product, 2013 - 2024 (USD Million) 
TABLE 20 Middle East Drug Eluting Stent Market, by product, 2013 - 2024 (USD Million) 
TABLE 21 North America Drug Eluting Stent Market, by application, 2013 - 2024 (USD Million) 
TABLE 22 U.S. Drug Eluting Stent Market, by application, 2013 - 2024 (USD Million) 
TABLE 23 Canada Drug Eluting Stent Market, by application, 2013 - 2024 (USD Million) 
TABLE 24 Europe Drug Eluting Stent Market, by application, 2013 - 2024 (USD Million) 
TABLE 25 Germany Drug Eluting Stent Market, by application, 2013 - 2024 (USD Million) 
TABLE 26 U.K. Drug Eluting Stent Market, by application, 2013 - 2024 (USD Million) 
TABLE 27 Spain Drug Eluting Stent Market, by application, 2013 - 2024 (USD Million) 
TABLE 28 Rest of Europe Drug Eluting Stent Market, by application, 2013 - 2024 (USD Million) 
TABLE 29 Asia Pacific Drug Eluting Stent Market, by application, 2013 - 2024 (USD Million) 
TABLE 30 China Drug Eluting Stent Market, by application, 2013 - 2024 (USD Million) 
TABLE 31 Japan Drug Eluting Stent Market, by application, 2013 - 2024 (USD Million) 
TABLE 32 India Drug Eluting Stent Market, by application, 2013 - 2024 (USD Million) 
TABLE 33 Rest of Asia Pacific Drug Eluting Stent Market, by application, 2013 - 2024 (USD Million)
TABLE 34 Latin America Drug Eluting Stent Market, by application, 2013 - 2024 (USD Million) 
TABLE 35 Brazil Drug Eluting Stent Market, by application, 2013 - 2024 (USD Million) 
TABLE 36 Mexico Drug Eluting Stent Market, by application, 2013 - 2024 (USD Million) 
TABLE 37 Rest of Latin America Drug Eluting Stent Market, by application, 2013 - 2024 (USD Million) 
TABLE 38 MEA Drug Eluting Stent Market, by application, 2013 - 2024 (USD Million) 
TABLE 39 South Africa Drug Eluting Stent Market, by application, 2013 - 2024 (USD Million) 
TABLE 40 Middle East Drug Eluting Stent Market, by application, 2013 - 2024 (USD Million)